Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. TBRG
TBRG logo

TBRG Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
25.850
Open
25.750
VWAP
25.81
Vol
143.92K
Mkt Cap
387.43M
Low
25.750
Amount
3.71M
EV/EBITDA(TTM)
8.11
Total Shares
15.00M
EV
527.20M
EV/OCF(TTM)
14.26
P/S(TTM)
1.08
TruBridge, Inc. is a provider of healthcare solutions and services for community hospitals, their clinics and other healthcare systems. The Company’s segments are Financial Health and Patient Care. The Financial Health reporting segment focuses on providing a complete revenue cycle management (RCM) solution for all care settings, regardless of their primary healthcare information solutions provider, along with business management, consulting, managed IT services, analytics, and business intelligence. The Patient Care segment provides comprehensive acute care solutions and related services for community hospitals and their physician clinics. The Patient Care segment also offers comprehensive patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. Its HFMA Peer Reviewed suite of RCM offerings combines visibility and transparency to enhance productivity and support the financial health of healthcare organizations.
Show More

Events Timeline

(ET)
2026-05-08
16:10:00
TruBridge Reports Q1 Revenue of $86.3M
select
2026-04-27 (ET)
2026-04-27
08:40:00
Deutsche Bank Raises TruBridge Price Target to $26.25
select
2026-04-24 (ET)
2026-04-24
08:30:00
BMO Raises TruBridge Price Target to $26.25
select
2026-04-24
07:30:00
Freedom Capital Downgrades TruBridge to Hold with $26.25 Price Target
select
2026-04-23 (ET)
2026-04-23
10:20:00
TruBridge Resumes, Up 12% After IKS Health Takeover Agreement
select
2026-04-23
09:50:00
IKS Health Enters Agreement to Acquire TruBridge for $26.25 per Share
select
2026-04-23
09:40:00
IKS Health to Acquire TruBridge for $26.25 per Share
select
2026-04-23
09:30:00
Computer Programs and Systems Inc Trading Halted, News Pending
select

News

PRnewswire
7.0
05-08PRnewswire
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
  • Investigation Background: Halper Sadeh LLC is investigating Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) regarding its sale to Angelini Pharma S.p.A. for $31.50 per share, as potential violations of shareholder rights may exist, prompting shareholders to understand their rights and options.
  • Transaction Details: TruBridge, Inc. (NASDAQ:TBRG) is being sold to Inventurus Knowledge Solutions, Inc. for $26.25 per share in cash, with Halper Sadeh LLC urging shareholders to be aware of potential legal rights and compensation opportunities.
  • Merger Impact: Following the proposed transaction, Modiv Industrial, Inc. (NYSE:MDV) shareholders are expected to own approximately 11% of the combined company, and Halper Sadeh LLC may seek increased compensation for shareholders.
  • Legal Support: Halper Sadeh LLC represents investors globally, focusing on legal remedies for securities fraud and corporate misconduct, emphasizing its successful track record in implementing corporate reforms and recovering funds for defrauded investors.
PRnewswire
7.0
05-06PRnewswire
TruBridge Faces Securities Claims Investigation
  • Securities Claims Investigation: Rosen Law Firm is investigating potential securities claims against TruBridge, Inc. (NASDAQ:TBRG) for allegedly issuing materially misleading business information, which may entitle investors to compensation without any out-of-pocket fees.
  • Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Notification of Late Filing on Form 12b-25, indicating its inability to file the Annual Report for the fiscal year ended December 31, 2025, due to the identification of errors in previously issued financial statements, which could undermine investor confidence in the company's financial health.
  • Stock Price Impact: Following this news, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns over the company's financial transparency and potential investor losses.
  • Legal Action Preparation: Rosen Law Firm is preparing a class action to recover investor losses, emphasizing the importance of selecting qualified counsel with a successful track record to effectively protect investors' rights.
PRnewswire
7.0
05-04PRnewswire
Investor Rights Law Firm Investigates Multiple Companies for Potential Violations
  • Legal Investigation Launched: Halper Sadeh LLC is investigating Organon & Co. (NYSE:OGN) regarding its sale to Sun Pharmaceutical Industries Limited at $14.00 per share, which may involve breaches of shareholder rights.
  • Shareholder Rights Protection: TruBridge, Inc. (NASDAQ:TBRG) is being sold to Inventurus Knowledge Solutions, Inc. for $26.25 per share in cash, and Halper Sadeh LLC encourages shareholders to understand their legal rights and options to ensure fair treatment.
  • Merger Transaction Review: The merger between Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) and Korsana Biosciences, Inc. is expected to result in Cyclerion shareholders owning approximately 1.5% of the combined company, with Halper Sadeh LLC potentially seeking increased consideration and additional disclosures.
  • Investor Protection Actions: Halper Sadeh LLC represents investors globally, focusing on combating securities fraud and corporate misconduct, having successfully recovered millions for defrauded investors, highlighting its crucial role in safeguarding shareholder interests.
Globenewswire
7.0
05-04Globenewswire
TruBridge Faces Securities Claims Investigation
  • Securities Claims Investigation: Rosen Law Firm is investigating potential securities claims against TruBridge, Inc. (NASDAQ: TBRG) for possibly issuing materially misleading business information, highlighting significant risks to corporate governance and transparency.
  • Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Form 12b-25 indicating its inability to timely submit its Annual Report for the fiscal year 2025 due to the identification of errors in previously issued financial statements, which may lead to decreased investor confidence and impact stock prices.
  • Stock Price Decline: Following the announcement of the delayed financial report, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns regarding the company's financial health and stability.
  • Class Action Preparation: Rosen Law Firm is preparing a class action lawsuit, allowing investors to seek compensation without any out-of-pocket fees, which may attract more affected investors and increase the legal risks faced by the company.
Globenewswire
7.0
04-30Globenewswire
TruBridge Faces Securities Claims Investigation
  • Securities Claims Investigation: Rosen Law Firm is investigating potential securities claims against TruBridge, Inc. (NASDAQ: TBRG) due to allegations of issuing materially misleading business information, indicating significant deficiencies in the company's disclosure practices.
  • Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Notification of Late Filing on Form 12b-25, citing the identification of errors in previously issued financial statements as the reason for not filing its Annual Report for the fiscal year ended December 31, 2025, which could undermine investor confidence in the company's financial health.
  • Stock Price Impact: Following this news, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns regarding the company's financial transparency and management capabilities.
  • Class Action Preparation: Rosen Law Firm is preparing a class action lawsuit, allowing investors to seek compensation without any out-of-pocket costs, indicating that the legal risks faced by the company could lead to further financial losses and reputational damage.
Globenewswire
8.5
04-30Globenewswire
Investigation into Multiple Corporate Mergers
  • TruBridge Acquisition: TruBridge, Inc. is under investigation regarding its sale to Inventurus Knowledge Solutions, Inc., with shareholders expected to receive $26.25 per share in cash, indicating a strong market expectation for this transaction's positive impact on shareholder value.
  • UniFirst Transaction Details: UniFirst Corporation is set to be acquired by Cintas Corporation, with shareholders entitled to $155.00 in cash and 0.7720 shares of Cintas stock per UniFirst share, which not only enhances UniFirst's market valuation but also provides Cintas with an opportunity to expand its market share.
  • Mister Car Wash Acquisition: Mister Car Wash, Inc. is being sold to MCW Parent, LP, with shareholders receiving $7.00 per share in cash, reflecting a trend of consolidation in the car wash industry that may influence future competitive dynamics.
  • Barinthus Merger: Barinthus Biotherapeutics plc is merging with Clywedog Therapeutics, Inc., where Barinthus shareholders will receive one share of the new combined company for each share owned, while Clywedog shareholders will receive 4.358932 shares, potentially strengthening both companies' competitive positions in the biotherapeutics sector.
Wall Street analysts forecast TBRG stock price to rise
2 Analyst Rating
Wall Street analysts forecast TBRG stock price to rise
0 Buy
2 Hold
0 Sell
Hold
Current: 0.000
sliders
Low
21.00
Averages
22.00
High
23.00
Current: 0.000
sliders
Low
21.00
Averages
22.00
High
23.00
Cantor Fitzgerald
Overweight
to
Neutral
downgrade
$25
AI Analysis
2026-04-23
Reason
Cantor Fitzgerald
Price Target
$25
AI Analysis
2026-04-23
downgrade
Overweight
to
Neutral
Reason
Cantor Fitzgerald downgraded TruBridge to Neutral from Overweight with a price target of $26.25, up from $25, after the company reached an agreement to be acquired by Inventurus Knowledge Solutions for $26.25 per share in cash.
Deutsche Bank
George Hill
Hold
maintain
$21 -> $23
2026-04-02
Reason
Deutsche Bank
George Hill
Price Target
$21 -> $23
2026-04-02
maintain
Hold
Reason
Deutsche Bank analyst George Hill raised the firm's price target on TruBridge to $23 from $21 and keeps a Hold rating on the shares. The firm views the company's Q4 report as inline and attributes the stock move to a "relief rally."
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for TBRG
Unlock Now

Valuation Metrics

The current forward P/E ratio for TruBridge Inc (TBRG.O) is 9.76, compared to its 5-year average forward P/E of 11.65. For a more detailed relative valuation and DCF analysis to assess TruBridge Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PE
11.65
Current PE
9.76
Overvalued PE
14.49
Undervalued PE
8.80

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average EV/EBITDA
8.44
Current EV/EBITDA
7.62
Overvalued EV/EBITDA
10.05
Undervalued EV/EBITDA
6.83

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
1.00
Current PS
1.04
Overvalued PS
1.40
Undervalued PS
0.60

Financials

AI Analysis
Annual
Quarterly

Whales Holding TBRG

P
Paradigm Capital Management, Inc.
Holding
TBRG
+23.64%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is TruBridge Inc (TBRG) stock price today?

The current price of TBRG is 25.83 USD — it has increased 0.19

What is TruBridge Inc (TBRG)'s business?

TruBridge, Inc. is a provider of healthcare solutions and services for community hospitals, their clinics and other healthcare systems. The Company’s segments are Financial Health and Patient Care. The Financial Health reporting segment focuses on providing a complete revenue cycle management (RCM) solution for all care settings, regardless of their primary healthcare information solutions provider, along with business management, consulting, managed IT services, analytics, and business intelligence. The Patient Care segment provides comprehensive acute care solutions and related services for community hospitals and their physician clinics. The Patient Care segment also offers comprehensive patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. Its HFMA Peer Reviewed suite of RCM offerings combines visibility and transparency to enhance productivity and support the financial health of healthcare organizations.

What is the price predicton of TBRG Stock?

Wall Street analysts forecast TBRG stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TBRG is22.00 USD with a low forecast of 21.00 USD and a high forecast of 23.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is TruBridge Inc (TBRG)'s revenue for the last quarter?

TruBridge Inc revenue for the last quarter amounts to 87.79M USD, decreased 0.00

What is TruBridge Inc (TBRG)'s earnings per share (EPS) for the last quarter?

TruBridge Inc. EPS for the last quarter amounts to -0.28 USD, decreased -28.21

How many employees does TruBridge Inc (TBRG). have?

TruBridge Inc (TBRG) has 3500 emplpoyees as of May 09 2026.

What is TruBridge Inc (TBRG) market cap?

Today TBRG has the market capitalization of 387.43M USD.